Baillie Gifford & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-82
| Closed | -$8.49K | – | 456 |
|
|
2022
Q4 | $8.49K | Hold |
82
| – | – | ﹤0.01% | 423 |
|
|
2022
Q3 | $7K | Hold |
82
| – | – | ﹤0.01% | 428 |
|
|
2022
Q2 | $7K | Hold |
82
| – | – | ﹤0.01% | 435 |
|
|
2022
Q1 | $6K | Hold |
82
| – | – | ﹤0.01% | 457 |
|
|
2021
Q4 | $7K | Hold |
82
| – | – | ﹤0.01% | 464 |
|
|
2021
Q3 | $6K | Hold |
82
| – | – | ﹤0.01% | 474 |
|
|
2021
Q2 | $7K | Hold |
82
| – | – | ﹤0.01% | 448 |
|
|
2021
Q1 | $6K | Buy |
82
+8
| +11% | +$585 | ﹤0.01% | 427 |
|
|
2020
Q4 | $6K | Buy |
+74
| New | +$6K | ﹤0.01% | 410 |
|
|
2013
Q4 | – | Sell |
-5,949
| Closed | -$430K | – | 209 |
|
|
2013
Q3 | $430K | Hold |
5,949
| – | – | ﹤0.01% | 180 |
|
|
2013
Q2 | $332K | Buy |
+5,949
| New | +$332K | ﹤0.01% | 155 |
|